| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-13 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |